NCT03806998View on ClinicalTrials.gov

Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Renal Failure
Interventions
DIETARY_SUPPLEMENT

Ketoacids

Provision of 1 Tablet containing 630 mg of ketoacids every 5 kg of body weight during 16 weeks

DIETARY_SUPPLEMENT

Placebo

Provision of placebo capsules similar to active supplement

Trial Locations (1)

Unknown

Hospital del Salvador, Santiago

All Listed Sponsors
collaborator

Servicio de Salud Metropolitano Oriente

UNKNOWN

lead

University of Chile

OTHER

NCT03806998 - Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure | Biotech Hunter | Biotech Hunter